Infection Current Awareness Update 14/02/2022
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Infection Current Awareness Update – 14/02/2022 Welcome to the weekly Infection Current Awareness Update (ICAU), produced by UKHSA Knowledge and Library Services. The purpose of this update is to provide you with the latest, best evidence about infection, to help you make informed decisions. Please note: UKHSA KLS has set up a separate COVID-19 Daily Alert of latest research. If you would like to receive this, please email libraries@phe.gov.uk. In addition to this, a page of resources about the coronavirus is available here. If you have any queries, please contact us at libraries@phe.gov.uk, and if you would like to request a literature search, please use the Knowledge and Library Services Enquiries Portal. Please note that not all the articles and resources referred to in this alert are freely available. Some articles may require an Athens username and password. For further information on Athens accounts please visit here. If you are not eligible to access our library services, then you may want to approach your local NHS library service. We do not accept responsibility for the availability or reliability of the items of content included in this alert and their inclusion is not an endorsement of any views that may be expressed. COVID-19 related research • COVID-19 infection - 1 Infection-related guidance • British Society for Antimicrobial Chemotherapy - 1 • European Centre for Disease Prevention and Control - 2 • Infectious Diseases Society of America - 1 Infection-related journals • American Journal of Infection Control - 15 • Clinical Infectious Diseases - Advance Access - 28 • Clinical Infectious Diseases - Current Issue - 38 • Clinical Microbiology and Infection - 14 • Clinical Microbiology Reviews - Current Issue - 1 • Current Opinion in Microbiology - 1 • Current Opinion in Virology - 3 • Diagnostic Microbiology and Infectious Disease - 1 • Emerging Infectious Diseases Journal - ahead of print - 18 • European Journal of Clinical Microbiology & Infectious Diseases - 10 • Eurosurveillance latest updates - 6 • Infection - 5 • Infection Control & Hospital Epidemiology - FirstView Article - 5 • International Journal of Infectious Diseases - 22 • Journal of Clinical Microbiology - 1
• Journal of Hospital Infection - 6 • Journal of Infection - 8 • Journal of Infection Prevention - 3 • Journal of Infectious Diseases - 26 • Journal of Medical Microbiology - 2 • Journal of Virology Current Issue - 3 • Journal of Virology: Articles Published Ahead of Print - 1 • Lancet - 2 • Microbiology and Molecular Biology Reviews: Current Issue - 1 • Morbidity and Mortality Weekly Report (MMWR) - 9 • Nature Reviews Microbiology - Current Issue - 4 • New England Journal of Medicine - Current Issue - 3 • Scandinavian Journal of Infectious Diseases: Table of Contents - 4 • Sexually Transmitted Infection Online First - 5 NIS Affiliation • PubMed: NIS affiliation - 6 COVID-19 related research COVID-19 infection WHO covid-19 drugs guideline: reconsider using convalescent plasma 08 Feb 2022 On 6 December the World Health Organization recommended against using covid-19 convalescent plasma (CCP) to treat covid-19 based on a statistical summary of selected randomised controlled trials... [back to top] Infection-related guidance British Society for Antimicrobial Chemotherapy Experts call for global network of superbug-detecting labs following infection coalition launch 09 Feb 2022 BSAC has joined the Infection Management Coalition (IMC), which brings together industry and charity leaders to help transform the way infection is detected, monitored, prevented, and managed, underpinned by the establishment of a global network of hospital-based, community-based and mobile laboratories to track the spread of antimicrobial resistance (AMR). [back to top] European Centre for Disease Prevention and Control COVID-19 vaccine effectiveness in adolescents aged 12–17 years and interim public health considerations for administration of a booster dose 08 Feb 2022 of protection against infection, symptomatic disease, and severe disease. There is limited evidence Multi-country outbreak of Salmonella Enteritidis sequence type (ST)11 infections linked to eggs and egg products 08 Feb 2022
On 2 September 2021, France reported an increase in Salmonella Enteritidis ST11 infections. By 11 January 2022, 272 confirmed cases had been reported in five European Union/European Economic Area (EU/EEA) countries and the United Kingdom (UK): Denmark (n=3), France (n=216), the Netherlands (n=12), Norway (n=7), Spain (n=22), and the UK (n=12) in 2021. Two deaths were recorded in adult men [back to top] Infectious Diseases Society of America An article in OFID describes a case of bacteremia in a person with HIV caused by a B. pertussis strain lacking two major virulence factors, suggesting even attenuated strains can cause invasive infection in the immunocompromised. :https://t.co/1O8wME1d2G @PaulSaxMD @DrJLi https://t.co/6GC4dZwTcW 12 Feb 2022 An article in OFID describes a case of bacteremia in a person with HIV caused by a B. pertussis strain lacking two major virulence factors, suggesting even attenuated strains can cause invasive infection in the immunocompromised. :https://bit.ly/3uyaL2D @PaulSaxMD @DrJLi [back to top] Infection-related journals American Journal of Infection Control Risk factors and clinical outcomes for Clostridioides difficile infections in a case control study at a large cancer referral center in Mexico 12 Feb 2022 Clostridioides difficile infection (CDI) is recognized as the leading cause of nosocomial diarrhea associated with the use of antibiotics and the most frequent healthcare-associated infection in high-income countries1. In 2017, this infection caused 462,000 cases, 224,000 hospitalizations, and 20,500 in-hospital-related deaths2, with annual attributable costs of 6.3 billion dollars3 Identification of Novel Factors Associated with Inappropriate Treatment of Asymptomatic Bacteriuria in Acute and Long-term Care 11 Feb 2022 Asymptomatic bacteriuria (ASB), or bacteria in the urine when the patient lacks an evidence- based symptom of a urinary tract infection (UTI), occurs at varying rates across different populations.1 The prevalence in healthy adult men and women has ranged from 1-2% and 1- 9%, respectively, while higher rates have been seen in pregnant women (15%), diabetic adults (30%), institutionalized adults Developing Valid Test Bank of Surveillance Case Study Scenarios for Inter-rater Reliability 11 Feb 2022 Case studies are utilized for training on National Healthcare Safety Network (NHSN) healthcare associated infection surveillance definitions. Item discrimination and item analysis were applied to case studies to identify questions that most accurately assess infection preventionists (IPs) application of surveillance definitions. Performance of a multidisciplinary team and the impact of bundles for reducing health care associated infections in adult intensive care unit: 22 years of experience 11 Feb 2022
Health care associated infections (HAI) are responsible for increased length of stay, cost of hospitalization, and high morbidity and mortality. Some authors report that 10-70% of infections can be avoided if prevention and control measures (bundles) are implemented Racial and Ethnic Differences in Vaccine Hesitancy among Registered Nurses in New Jersey: A Cross-Sectional Survey 11 Feb 2022 Nurses play an important role in the vaccine readiness process and high vaccination rates among nurses are essential to ensuring successful vaccination programs. This study sought to examine whether the intention to get vaccinated varied by race/ethnicity among a large sample of registered nurses in New Jersey. Systematic review of ultrasound gel associated Burkholderia cepacia complex outbreaks: clinical presentation, causes and outbreak control 11 Feb 2022 The members of the Burkholderia cepacia complex (Bcc) are Gram-negative bacilli which are increasingly being reported as opportunistic human pathogens.1, 2, 3 Bcc rarely causes disease in immunocompetent individuals and is recognized as a serious pathogen in cystic fibrosis patients.4 Burkholderia species are also reported as a major cause of sepsis The feasibility of procalcitonin and CPIS score to reduce inappropriate antibiotics use among severe-critically ill COVID-19 pneumonia patients: A pilot study 11 Feb 2022 COVID-19 pneumonia is associated with a mortality up to 20% varying by country1 with the number of global deaths over 5 million.2 Antibiotics have been extensively used in COVID-19 patients in intensive care units (ICUs) without a clear indication.3 According to a previous study, the frequency of bacterial pneumonia in COVID-19 patients was 6.9%, while >70% of patients received antibiotics Comparison of the certified Copan eSwabTM system with commercially available cotton swabs for the detection of multidrug-resistant bacteria in rectal swabs 11 Feb 2022 Due to the ongoing coronavirus disease 2019 (COVID-19) pandemic, the World Health Organization (WHO) recommended on March 16, 2020 to carry out nasopharyngeal swabs for the detection of SARS-CoV-2 as extensively as possible to contain the pandemic1: “You cannot fight a fire blindfolded […]. We have a simple message for all countries: test, test, test Comparison of filtration efficiency and respiratory resistance of COVID- 19 protective masks by multi-national standards 11 Feb 2022 In March 2020, the World Health Organization (WHO) declared the novel coronavirus pandemic (COVID-19) that had spread rapidly around the world and caused thousands of deaths.1 As of 18 September 2021, more than 227 million cases and 4.67 million deaths have been confirmed, making it one of the deadliest pandemics in history Strategies Utilized to Prevent and Control SARS-CoV-2 Transmission in Two Congregate, Psychiatric Healthcare Settings During the Pandemic 11 Feb 2022 COVID-19 was declared a global pandemic on March 11, 2020 1. The pandemic has substantially affected both the mental health of people around the world, as well as the delivery of psychiatric health care. Patients with psychiatric conditions experience higher incidences of chronic medical conditions that may put them at risk for increased morbidity and mortality from COVID-19 2–5 Comparing the effectiveness of hand hygiene techniques in reducing the microbial load and covering hand surfaces in healthcare workers: updated systematic review 11 Feb 2022
It is widely acknowledged that effective hand hygiene (HH) among healthcare workers (HCWs) is one of the most important infection prevention strategies available1, 2; and therefore, is a key element of infection prevention and control guidelines.3 However, uncertainty remains concerning a range of issues related to HH.2, 4 Correlation between hospital-onset and community-onset Clostridioides difficile infection incidence: ward-level analysis following hospital relocation 11 Feb 2022 Clostridioides difficile (C. difficile) is a leading cause of nosocomial infections. It is a spore- forming anaerobic bacillus that is mainly transmitted through direct or indirect contact with infected patients and asymptomatic carriers.1,2 Patients asymptomatically colonized by toxigenic strains may progress to C. difficile infection (CDI) during admission Carbapenemase-producing Enterobacterales and vancomycin-resistant Enterococcus faecium carriage in patients who have traveled in foreign countries: a single center 5-year prospective study 11 Feb 2022 Numerous patients carrying carbapenemase-producing Enterobacterales (CPE) and/or vancomycin-resistant Enterococcus faecium (VRE) in France have previously travelled abroad. The risk of spreading CPE/VRE by patients who have stayed abroad without hospitalization is underexplored Focused Multivector Ultraviolet (FMUV) Technology Rapidly Eradicates SARS-CoV-2 in-vitro: Implications for Hospital Disinfection of COVID- 19 Environments 10 Feb 2022 Focused Multivector Ultraviolet (FMUV) technology rapidly killed the SARS-CoV-2 coronavirus in-vitro. Plates were inoculated with a mean of greater than 106 plaque forming units (PFUs) of USA-WA1 Washington index patient strain of SARS-CoV-2 and exposed to ultraviolet, resulting in mean reductions of 99.99% within 30 seconds, 99.999% within 60 seconds, and 99.9999% within 90 seconds Comparing surgeons’ skin tolerance and acceptability to alcohol-based surgical hand preparation versus traditional surgical scrub: a matched quasi-experimental study 09 Feb 2022 Surgical site infections (SSIs) are a major cause of postoperative morbidity and mortality, and increase healthcare-related costs.1,2 A multicentre survey carried out among 25 healthcare facilities in the US showed that pneumonia, gastrointestinal infections, and SSIs were the most frequent healthcare-associated infections (HAI) [back to top] Clinical Infectious Diseases - Advance Access Self-Assessed Severity as a Determinant of COVID-19 Symptom Specificity: A Longitudinal Cohort Study 13 Feb 2022 Inequities in COVID-19 vaccination rates among adolescents in Massachusetts: a cross-sectional study 13 Feb 2022 Cefiderocol for the Treatment of Infections Due To Metallo-Beta- Lactamase-Producing Pathogens in the CREDIBLE-CR And APEKS- NP Phase 3 Randomized Studies 11 Feb 2022 Respiratory virus burden in the community: more than what meets the eye 11 Feb 2022
AmBisome monotherapy and combination AmBisome – miltefosine therapy for the treatment of visceral leishmaniasis in patients co- infected with HIV in India: a randomised open label, parallel arm, phase 3 trial 11 Feb 2022 Lower rates of emergency visits and hospitalizations among chronic hepatitis C patients with sustained virological response to interferon- free direct-acting antiviral therapy (2014–2018) 11 Feb 2022 Household transmission of SARS-CoV-2 Alpha variant – United States, 2021 11 Feb 2022 Antibiotic Stewardship Strategies and Their Association with Antibiotic Overuse after Hospital Discharge: An Analysis of the Reducing Overuse of Antibiotics at Discharge (Road) Home Framework 10 Feb 2022 Model-based analysis of tuberculosis genotype clusters in the United States reveals high degree of heterogeneity in transmission, and state- level differences across California, Florida, New York, and Texas 10 Feb 2022 Comparing Covid-19 pandemic waves in hospitalized patients – a retrospective, multicenter, cohort study 10 Feb 2022 Genital immune cell activation and tenofovir gel efficacy: a case-control study 10 Feb 2022 The rapid reduction of infection-related visits and antibiotic use among people with cystic fibrosis after starting Elexacaftor-Tezacaftor-Ivacaftor 10 Feb 2022 Outbreak of Respiratory Syncytial Virus Bronchiolitis in Italy 10 Feb 2022 Real-world Effectiveness of the SARS-CoV-2 mRNA Vaccines in Preventing Confirmed Infection in Patients on Chronic Hemodialysis 09 Feb 2022 Infectious Diseases-Related Hospitalizations During Oral Polio Vaccine(OPV) and non-OPV immunization periods: An Empirical Evaluation of all Hospital Discharges in California(1985-2010) 09 Feb 2022 Predictors of SARS-CoV-2 infection: is there a comprehensive analysis? 08 Feb 2022 Re-emergence of Invasive Pneumococcal Disease in Germany during the Spring and Summer of 2021 07 Feb 2022 Effectiveness of BNT162b2 and mRNA-1273 Second Doses and Boosters for SARS-CoV-2 infection and SARS-CoV-2 Related Hospitalizations: A Statewide Report from the Minnesota Electronic Health Record Consortium 07 Feb 2022
Melioidosis of the central nervous system; impact of the bimABm allele on patient presentation and outcome 07 Feb 2022 The International Sexual Health And Reproductive Health Survey (I- SHARE-1): A Multi-Country Analysis of Adults from 30 Countries Prior to and During the Initial COVID-19 Wave 07 Feb 2022 Social vulnerability and rurality associated with higher SARS-CoV-2 infection-induced seroprevalence: a nationwide blood donor study, United States, July 2020 – June 2021 07 Feb 2022 Comparative Effectiveness of COVID-19 Vaccines against the Delta Variant 07 Feb 2022 Rapid control of hospital-based SARS-CoV-2 Omicron clusters through daily testing and universal use of N95 respirators 07 Feb 2022 Cefiderocol for the treatment of metallo-beta-lactamases producing Gram negative bacilli: lights and shadows from the literature 05 Feb 2022 Infective endocarditis among high-risk individuals - before and after the cessation of antibiotic prophylaxis in dentistry: a national cohort study 04 Feb 2022 Efficacy, Safety, Pharmacokinetics, and Microbiome Changes of Ibezapolstat in Adults with Clostridioides difficile Infection: A Phase 2a Multicenter Clinical Trial 04 Feb 2022 Evolution of imipenem-relebactam resistance following treatment of multidrug-resistant Pseudomonas aeruginosa pneumonia 04 Feb 2022 Trend in Sensitivity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Serology One Year After Mild and Asymptomatic Coronavirus Disease 2019 (COVID-19): Unpacking Potential Bias in Seroprevalence Studies 13 Jan 2022 [back to top] Clinical Infectious Diseases - Current Issue Molecular Epidemiology, Natural History, and Long-Term Outcomes of Multidrug-Resistant Enterobacterales Colonization and Infections Among Solid Organ Transplant Recipients 11 Feb 2022 M Hong Nguyen, Ryan K Shields, Liang Chen, A William Pasculle, Binghua Hao ... Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 395–406, https://doi.org/10.1093/cid/ciab427 Twenty-five percent of transplant recipients were gastrointestinally colonized by multidrug-resistant Enterobacterales, which predisposed to invasive infections Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity by Viral Load, S Gene Variants and Demographic Factors, and the Utility of Lateral Flow Devices to Prevent Transmission
11 Feb 2022 Lennard Y W Lee, Stefan Rozmanowski, Matthew Pang, Andre Charlett, Charlotte Anderson ... Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 407–415, https://doi.org/10.1093/cid/ciab421 In 2,474,066 contacts of 1,064,004 SARS-CoV-2 cases, PCR-positive tests in contacts increased with higher index case viral loads, the B.1.1.7 variant and household contact Trends Over Time in the Risk of Adverse Outcomes Among Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection 11 Feb 2022 George N Ioannou, Ann M O’Hare, Kristin Berry, Vincent S Fan, Kristina Crothers ... Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 416–426, https://doi.org/10.1093/cid/ciab419 The risk of adverse outcomes in patients with severe acute respiratory syndrome coronavirus 2 infection declined substantially from February to July 2020, and subsequently plateaued from July to Risk Factors for Infection and Health Impacts of the Coronavirus Disease 2019 (COVID-19) Pandemic in People With Autoimmune Diseases 11 Feb 2022 Kathryn C Fitzgerald, Christopher A Mecoli, Morgan Douglas, Samantha Harris, Berna Aravidis ... Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 427– 436, https://doi.org/10.1093/cid/ciab407 A large study of people with autoimmune or inflammatory conditions finds that glucocorticoid exposure may increase risk of coronavirus disease 2019 (COVID-19) Sustained Declines in Age Group-Specific Rotavirus Infection and Acute Gastroenteritis in Vaccinated and Unvaccinated Individuals During the 5 Years Since Rotavirus Vaccine Introduction in England 11 Feb 2022 Charlotte M Gower, Julia Stowe, Nick J Andrews, Jake Dunning, Mary E Ramsay ... Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 437–445, https://doi.org/10.1093/cid/ciab460 There were 69–83% reductions in laboratory-confirmed rotavirus infections and 12–35% reductions in all-cause acute gastroenteritis hospitalizations across all age-groups in the 5 years after rotavirus First Case of Lethal Encephalitis in Western Europe Due to European Bat Lyssavirus Type 1 11 Feb 2022 Béatrice Regnault, Bruno Evrard, Isabelle Plu, Laurent Dacheux, Eric Troadec ... Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 461–466, https://doi.org/10.1093/cid/ciab443 European Bat Lyssavirus type 1 is prevalent in bats in Europe. We present the first human case identified in Western Europe Coronavirus Disease 2019 (COVID-19) Disease Severity: Pregnant vs Nonpregnant Women at 82 Facilities 11 Feb 2022 Albert L Hsu, Adrienne M Ohler, Andrea Goldstein, Sarah Truong, Cynthia Y Tang ... Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 467–471, https://doi.org/10.1093/cid/ciab441 In this retrospective cohort study of 38 106 individuals, COVID-19 disease severity and mortality are not statistically different between pregnant (n = 1420) and nonpregnant women (n = 18 089), Retreatment of Chronic Hepatitis C Infection: Real-World Regimens and Outcomes From National Treatment Programs in Three Low- and Middle-Income Countries 11 Feb 2022 Caroline E Boeke, Lindsey Hiebert, Imam Waked, Tengiz Tsertsvadze, Lali Sharvadze ... Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 513–516, https://doi.org/10.1093/cid/ciab461 Abstract View article
Evaluating the Presence of Replication-Competent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From Nursing Home Residents With Persistently Positive Reverse Transcription Polymerase Chain Reaction (RT-PCR) Results 11 Feb 2022 Joseph D Lutgring, Farrell A Tobolowsky, Kelly M Hatfield, Nicholas B Lehnertz, Maureen M Sullivan ... Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 525– 528, https://doi.org/10.1093/cid/ciab436 Abstract View article Reducing Influenza Virus Transmission: The Potential Value of Antiviral Treatment 11 Feb 2022 Frederick G Hayden, Jason Asher, Benjamin J Cowling, Aeron C Hurt, Hideyuki Ikematsu ... Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 532–540, https://doi.org/10.1093/cid/ciab625 Prompt antiviral treatment has the potential to reduce influenza virus transmission from infected persons to contacts Chronic Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in the Immunocompromised Patient: New Challenges and Urgent Needs 11 Feb 2022 Lorenzo Lodi, Maria Moriondo, Alessandra Pucci, Laura Pisano, Silvia Ricci ... Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Page 553, https://doi.org/10.1093/cid/ciab538 Extract View article Disparities in Coronavirus Disease 2019 Outcomes for African Americans: More Studies Are Warranted 11 Feb 2022 Shiva Mehravaran, Hussien Ahmed H Abdelgawad, Yun-Chi Chen Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 555–556, https://doi.org/10.1093/cid/ciab498 Extract View article Supplementary data Better Hybrid Systems for Disease Detections and Early Predictions 11 Feb 2022 Arni S R Srinivasa Rao, Jose A Vazquez Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 556–558, https://doi.org/10.1093/cid/ciab489 Extract View article Reply to author 11 Feb 2022 Zanthia Wiley, Katie Ross-Driscoll, Zhensheng Wang, Laken Smothers, Aneesh K Mehta ... Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Page 556, https://doi.org/10.1093/cid/ciab499 Extract View article It Is Time to Determine Tocilizumab’s Place in Coronavirus Disease 2019 (COVID-19) 11 Feb 2022 Klopfenstein Timothée, Aurélie Gerazime, Marc Puyraveau, N’dri Juliette Kadiane-Oussou, Vincent Gendrin ... Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 560–562, https://doi.org/10.1093/cid/ciab480 Extract View article Diphtheria, Tetanus, and Pertussis: Unequal Vaccine Siblings With Distinct Characteristics 11 Feb 2022 Ulrich Heininger Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 562–563, https://doi.org/10.1093/cid/ciaa643 Extract View article Invasive Fungal Infections in Lung Transplant Recipients 11 Feb 2022 Tina Marinelli, Coleman Rotstein Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 563–564, https://doi.org/10.1093/cid/ciaa603 Extract View article Reply to Author 11 Feb 2022
Radha Rajasingham, Eva A Enns, Byron P Vaughn Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Page 563, https://doi.org/10.1093/cid/ciaa740 Extract View article Racial and Ethnic Differences and Clinical Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) Presenting to the Emergency Department 11 Feb 2022 Zanthia Wiley, Katie Ross-Driscoll, Zhensheng Wang, Laken Smothers, Aneesh K Mehta ... Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 387–394, https://doi.org/10.1093/cid/ciab290 Blacks and Hispanics comprised 60.3% of emergency department patients with COVID-19. Compared with Whites, hospitalization risks were similar between racial/ethnic groups Novel Canine Coronavirus Isolated from a Hospitalized Patient With Pneumonia in East Malaysia 11 Feb 2022 Anastasia N Vlasova, Annika Diaz, Debasu Damtie, Leshan Xiu, Teck-Hock Toh ... Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 446–454, https://doi.org/10.1093/cid/ciab456 This is the first complete genome characterization of a novel canine-feline recombinant alphacoronavirus isolated from a child with pneumonia Azithromycin and Ciprofloxacin Treatment Outcomes During an Outbreak of Multidrug-Resistant Shigella sonnei Infections in a Retirement Community—Vermont, 2018 11 Feb 2022 Radhika Gharpure, Cindy R Friedman, Veronica Fialkowski, Jennifer P Collins, Jonathan Strysko ... Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 455– 460, https://doi.org/10.1093/cid/ciab450 Among 24 patients in a multidrug-resistant Shigella outbreak, 4 were treated with azithromycin; all had clinical treatment failure (persistent diarrhea) and 2 also had microbiologic The Effectiveness of the Two-Dose BNT162b2 Vaccine: Analysis of Real-World Data 11 Feb 2022 Gabriel Chodick, Lilac Tene, Ran S Rotem, Tal Patalon, Sivan Gazit ... Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 472–478, https://doi.org/10.1093/cid/ciab438 We assessed the effectiveness of the BNT162b2 coronavirus disease 2019 (COVID-19) vaccine among 1.2 million vaccinees Increased Peripheral Blood Neutrophil Activation Phenotypes and Neutrophil Extracellular Trap Formation in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients: A Case Series and Review of the Literature 11 Feb 2022 Jorge A Masso-Silva, Alexander Moshensky, Michael T Y Lam, Mazen F Odish, Arjun Patel ... Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 479–489, https://doi.org/10.1093/cid/ciab437 Neutrophils in the circulation of critically ill COVID-19 patients with acute respiratory distress syndrome have functional changes over the course of their disease Cruise Ship Travel in the Era of Coronavirus Disease 2019 (COVID- 19): A Summary of Outbreaks and a Model of Public Health Interventions 11 Feb 2022 Sarah Anne J Guagliardo, Pragati V Prasad, Andrea Rodriguez, Rena Fukunaga, Ryan T Novak ... Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 490–497, https://doi.org/10.1093/cid/ciab433 We analyze the largest available dataset on SARS-CoV-2 on cruises, and assess interventions using mathematical modeling Intersection of Syphilis and Human Immunodeficiency Virus (HIV) Networks to Identify Opportunities to Enhance HIV Prevention 11 Feb 2022
Ann M Dennis, Andrew Cressman, Dana Pasquale, Simon D W Frost, Elizabeth Kelly ... Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 498–506, https://doi.org/10.1093/cid/ciab431 HIV risk networks with high viremia were identified among 1289 minority men and transgender women diagnosed with early syphilis or new HIV infection Serotype-specific Cardiac Involvement in Pneumococcal Pneumonia 11 Feb 2022 Keith P Klugman, Charles Feldman Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 507–508, https://doi.org/10.1093/cid/ciaa1434 Extract View article Tuberculosis Elimination in the Era of Coronavirus Disease 2019 (COVID-19): A Moving Target 11 Feb 2022 Navisha Dookie, Nesri Padayatchi, Kogieleum Naidoo Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 509–510, https://doi.org/10.1093/cid/ciaa1400 Extract View article In the Fog of Coronavirus Disease (COVID) 11 Feb 2022 John A Zaia Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 511– 512, https://doi.org/10.1093/cid/ciaa1292 Extract View article BNT162b2 Messenger RNA Vaccination Did Not Prevent an Outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 Variant 501Y.V2 in an Elderly Nursing Home but Reduced Transmission and Disease Severity 11 Feb 2022 Benoit Bailly, Luc Guilpain, Kevin Bouiller, Catherine Chirouze, Melissa N’Debi ... Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 517–520, https://doi.org/10.1093/cid/ciab446 Abstract View article Supplementary data Significant Impact of Coronavirus Disease 2019 (COVID-19) on Human Immunodeficiency Virus (HIV) Care in Hospitals Affecting the First Pillar of the HIV Care Continuum 11 Feb 2022 Kathryn S Hensley, Carlijn C E Jordans, Jeroen J A van Kampen, Femke P N Mollema, Elisabeth H Gisolf ... Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 521–524, https://doi.org/10.1093/cid/ciab445 Abstract View article Supplementary data Universal Use of N95 Respirators in Healthcare Settings When Community Coronavirus Disease 2019 Rates Are High 11 Feb 2022 Michael Klompas, Chanu Rhee, Meghan A Baker Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 529–531, https://doi.org/10.1093/cid/ciab539 The risk of severe acute respiratory syndrome coronavirus 2 transmission is greatest before symptom onset Evaluating Vaccine Efficacy Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection 11 Feb 2022 Dan-Yu Lin, Yu Gu, Donglin Zeng, Holly E Janes, Peter B Gilbert Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 544–552, https://doi.org/10.1093/cid/ciab630 We show how to estimate potentially waning efficacy of coronavirus disease 2019 vaccines against severe acute respiratory syndrome coronavirus 2 infection using blood or nasal samples collected periodically from Neutralization Potential of Covishield Vaccinated Individuals Sera Against B.1.617.1 11 Feb 2022
Pragya D Yadav, Gajanan N Sapkal, Priya Abraham, Gururaj Deshpande, Dimpal A Nyayanit ... Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 558–559, https://doi.org/10.1093/cid/ciab483 Extract View article Useful Roles and Limitations for the Coccidioides Antigen Detection Enzyme Immunoassay 11 Feb 2022 Christelle Kassis, L Joseph Wheat Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Page 560, https://doi.org/10.1093/cid/ciab482 Extract View article Erratum 11 Feb 2022 Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Page 565, https://doi.org/10.1093/cid/ciaa1010 Extract View article In the Literature 11 Feb 2022 Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages i–ii, https://doi.org/10.1093/cid/ciac015 Extract View article Projected Impact and Cost-effectiveness of Community-based Versus Targeted Azithromycin Administration Strategies for Reducing Child Mortality in Sub-Saharan Africa 11 Feb 2022 Rebecca L Brander, Marcia R Weaver, Patricia B Pavlinac, Grace C John-Stewart, Stephen E Hawes ... Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 375– 386, https://doi.org/10.1093/cid/ciz1220 Mass distribution of empiric azithromycin may be highly cost-effective for reducing child mortality in sub-Saharan Africa, and targeting azithromycin to high-mortality groups is even Nonresolving Nodular Rash 11 Feb 2022 Bohdan P Savaryn, Justin Z Chen Clinical Infectious Diseases, Volume 74, Issue 3, 1 February 2022, Pages 541–543, https://doi.org/10.1093/cid/ciab316 Extract View article [back to top] Clinical Microbiology and Infection Re: 'non-biomedical factors affecting antibiotic use in the community' by Sun et al 13 Feb 2022 Publication date: Available online 12 February 2022Source: Clinical Microbiology and InfectionAuthor(s): Lindsey Laytner, Larissa Grigoryan, Barbara Trautner 'Predicting critical illness on initial diagnosis of COVID-19 based on easily-obtained clinical variables' – Author’s reply 11 Feb 2022 Publication date: Available online 10 February 2022Source: Clinical Microbiology and InfectionAuthor(s): Adrian Viteri-Nöel, Miguel Martínez-Lacalzada, Martin Fabregate, Luis Manzano Clostridioides difficile colonisation among very young children in resource-limited settings 10 Feb 2022 Publication date: Available online 10 February 2022Source: Clinical Microbiology and InfectionAuthor(s): Stephanie A. Brennhofer, Elizabeth T. Rogawski McQuade, Jie Liu, Richard L. Guerrant, James A. Platts-Mills, Cirle A. Warren Defining COVID-19 associated pulmonary aspergillosis: systematic review and meta-analysis 10 Feb 2022
Publication date: Available online 10 February 2022Source: Clinical Microbiology and InfectionAuthor(s): Ruwandi M. Kariyawasam, Tanis C. Dingle, Brittany E. Kula, Ben Vandermeer, Wendy I. Sligl, Ilan S. Schwartz Lower probability of persistence of total anti-SARS-CoV-2 antibodies after COVID-19 among people living with HIV 10 Feb 2022 Publication date: Available online 10 February 2022Source: Clinical Microbiology and InfectionAuthor(s): Juan Macías, Marta Fernández-Fuertes, Noemí Oliver, Anaïs Corma- Gómez, Luis M. Real, Juan A. Pineda IDSA guidance and ESCMID guidelines: complementary approaches toward a care standard for MDR Gram-negative infections 10 Feb 2022 Publication date: Available online 9 February 2022Source: Clinical Microbiology and InfectionAuthor(s): Alexander Lawandi, Christina Yek, Sameer S. Kadri Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil: a test-negative design study 10 Feb 2022 Publication date: Available online 9 February 2022Source: Clinical Microbiology and InfectionAuthor(s): Otavio T. Ranzani, Amanda A.B. Silva, Igor T. Peres, Bianca B.P. Antunes, Thiago W. Gonzaga-da-Silva, Daniel R. Soranz, José Cerbino-Neto, Silvio Hamacher, Fernando A. Bozza Evidence based dosing of convalescent plasma for COVID-19 in future trials 10 Feb 2022 Publication date: Available online 10 February 2022Source: Clinical Microbiology and InfectionAuthor(s): Bart JA. Rijnders, Sammy Huygens, Oriol Mitjà Posaconazole bioavailability of the solid oral tablet is reduced during severe intestinal mucositis 10 Feb 2022 Publication date: Available online 10 February 2022Source: Clinical Microbiology and InfectionAuthor(s): Anouk M.E. Jansen, Eline W. Muilwijk, Walter J.F.M. Van Der Velden, Johan A. Maertens, Robina Aerts, Angela Colbers, David Burger, Paul E. Verweij, Rob Ter Heine, Nicole M.A. Blijlevens, Roger J.M. Brüggemann External validation of the PRIORITY model in predicting COVID-19 critical illness in vaccinated and unvaccinated patients 10 Feb 2022 Publication date: Available online 10 February 2022Source: Clinical Microbiology and InfectionAuthor(s): Sean Wei Xiang Ong, Sai Meng Tham, Lin Pin Koh, Christopher Dugan, Bo Yan Khoo, Dongdong Ren, Stephanie Sutjipto, Pei Hua Lee, Barnaby Edward Young, David Chien Lye Assessing and restoring adaptive immunity to HSV, VZV and HHV-6 in solid organ and hematopoietic cell transplant recipients 10 Feb 2022 Publication date: Available online 10 February 2022Source: Clinical Microbiology and InfectionAuthor(s): Madeleine R. Heldman, Kaja M. Aagaard, Joshua A. Hill Low placental weight and altered metabolic scaling after severe acute respiratory syndrome coronavirus type 2 infection during pregnancy: a prospective multicentric study 10 Feb 2022 Publication date: Available online 10 February 2022Source: Clinical Microbiology and InfectionAuthor(s): Anda-Petronela Radan, David Baud, Guillaume Favre, Andrea Papadia, Daniel Surbek, Marc Baumann, Luigi Raio
Treatment of Coxiella burnetii endocarditis with hydroxychloroquine. Is it evidence-based? 10 Feb 2022 Publication date: Available online 9 February 2022Source: Clinical Microbiology and InfectionAuthor(s): J.P. Stahl, E. Varon, J.P. Bru The effect of a third BNT162b2 vaccine on breakthrough infections in healthcare workers: a cohort analysis 08 Feb 2022 Publication date: Available online 7 February 2022Source: Clinical Microbiology and InfectionAuthor(s): Yonatan Oster, Shmuel Benenson, Ran Nir-Paz, Inon Buda, Matan J. Cohen [back to top] Clinical Microbiology Reviews - Current Issue Bacillus cereus Invasive Infections in Preterm Neonates: an Up-to-Date Review of the Literature 09 Feb 2022 Clinical Microbiology Reviews, Ahead of Print. [back to top] Current Opinion in Microbiology Strain wars and the evolution of opportunistic pathogens 13 Feb 2022 Publication date: June 2022Source: Current Opinion in Microbiology, Volume 67Author(s): Samuel K Sheppard [back to top] Current Opinion in Virology Editorial Board 10 Feb 2022 Publication date: February 2022Source: Current Opinion in Virology, Volume 52Author(s): Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy 10 Feb 2022 Publication date: April 2022Source: Current Opinion in Virology, Volume 53Author(s): Guilherme Dias de Melo, Jan Hellert, Rajesh Gupta, Davide Corti, Hervé Bourhy Broad neutralizing antibody-based strategies to tackle influenza 07 Feb 2022 Publication date: April 2022Source: Current Opinion in Virology, Volume 53Author(s): Xiaoyu Sun, Zhiyang Ling, Zhuo Yang, Bing Sun [back to top] Diagnostic Microbiology and Infectious Disease Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection 13 Feb 2022 Publication date: Available online 12 February 2022Source: Diagnostic Microbiology and Infectious DiseaseAuthor(s): Jan Van Elslande, Matthijs Oyaert, Natalie Lorent, Yannick Vande Weygaerde, Gijs Van Pottelbergh, Lode Godderis, Marc Van Ranst, Emmanuel André, Elizaveta Padalko, Katrien Lagrou, Stien Vandendriessche, Pieter Vermeersch [back to top]
Emerging Infectious Diseases Journal - ahead of print Multisystem Inflammatory Syndrome in Adult after First Dose of mRNA Vaccine 11 Feb 2022 Y. Miyazato et al. Genomic and Phenotypic Insights for Toxigenic Clinical Vibrio cholerae O141 10 Feb 2022 Y. Hounmanou et al. Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related Applications 10 Feb 2022 M. Stone et al. Detection of SARS-CoV-2 in Neonatal Autopsy Tissues and Placenta 09 Feb 2022 S. Reagan-Steiner et al. Subcutaneous Nodules Caused by Tropheryma whipplei Infection 08 Feb 2022 L. Wang et al. SARS-CoV-2 Breakthrough Infections after introduction of 4 COVID-19 Vaccines, South Korea, 2021 08 Feb 2022 S. Yi et al. Treatment Outcomes of Childhood Tuberculous Meningitis in a Real- World Retrospective Cohort, Bandung, Indonesia 08 Feb 2022 H. M. Nataprawira et al. Sensitivity of Mycobacterium leprae to Telacebec 08 Feb 2022 R. Lahiri et al. Long-Term Symptoms among COVID-19 Survivors in Prospective Cohort Study, Brazil 08 Feb 2022 L. P. Bonifácio et al. Disseminated Histoplasmosis in Persons with HIV/AIDS, Southern Brazil, 2010–2019 08 Feb 2022 R. Basso et al. Transovarial Transmission of Heartland Virus by Invasive Asian Longhorned Ticks under Laboratory Conditions 07 Feb 2022 W. R. Raney et al. Restaurant-Based Measures to Control Community Transmission of COVID-19, Hong Kong 07 Feb 2022 F. Ho et al. Mycobacterium leprae Infection in a Wild Nine-Banded Armadillo, Nuevo León, Mexico 07 Feb 2022 L. Vera-Cabrera et al. Mycobacterium mageritense Lymphadenitis in Child
07 Feb 2022 M. García-Boyano et al. Higher Viral Stability and Ethanol Resistance of Avian Influenza A(H5N1) Virus on Human Skin 07 Feb 2022 R. Bandou et al. Case–Control Study of Clostridium innocuum Infection, Taiwan 04 Feb 2022 Y. Chen et al. Photo Quiz 04 Feb 2022 D. Orsini and M. Martini Spatiotemporal Analyses of 2 Co-Circulating SARS-CoV-2 Variants, New York State, USA 05 Jan 2022 A. Russell et al. [back to top] European Journal of Clinical Microbiology & Infectious Diseases False-positive immunochromatographic CTX-M enzyme test from direct testing of a positive blood culture 13 Feb 2022 Impact of FilmArray™ Respiratory Panel testing on the clinical management of pediatric bone marrow transplant patients 13 Feb 2022 Abstract Viral respiratory tract infections cause significant morbidity in bone marrow transplant (BMT) patients. Speed and sensitivity of the FilmArray™ Respiratory Panel (FA- RP) can improve care but may prompt inappropriate testing Performance of the eazyplex® BloodScreen GN as a simple and rapid molecular test for identification of Gram-negative bacteria from positive blood cultures 13 Feb 2022 Abstract The LAMP-based eazyplex® BloodScreen GN was evaluated for the detection of frequent Gram-negatives directly from positive blood culture (BC) bottles. A total of 449 BCs were analyzed. Sensitivities and specificities were 100% and 100% for Escherichia coli, 95 Direct detection of extended-spectrum-β-lactamase-producers in Enterobacterales from blood cultures: a comparative analysis 13 Feb 2022 Abstract Accurate detection of extended-spectrum-β-lactamase (ESBL)-producing Enterobacterales from bloodstream infection (BSI) is of paramount importance for both epidemiological and clinical purposes, especially for optimization of antibiotic stewardship interventions Correction to: Simplified therapeutic guidelines: the main tool of antimicrobial stewardship programs associated with optimal antibiotic therapy 13 Feb 2022 Rapid molecular detection of pathogenic microorganisms and antimicrobial resistance markers in blood cultures: evaluation and utility of the next-generation FilmArray Blood Culture Identification 2 panel 13 Feb 2022 Abstract Rapid detection of pathogens causing bloodstream infections (BSI) directly from positive blood cultures is of highest importance in order to enable an adequate and timely antimicrobial therapy
Increasing usage of chlorhexidine in health care settings: blessing or curse? A narrative review of the risk of chlorhexidine resistance and the implications for infection prevention and control 13 Feb 2022 Abstract Chlorhexidine digluconate (CHG) is an antiseptic frequently used in hospitals to prevent healthcare-related infections. It is used in different formulations for skin antisepsis, oral care, patient bathing, and hand hygiene. Also, CHG impregnated vascular catheters and wound dressings contribute to increased exposure of hospital germs to this biocide Correction to: Rapid molecular detection of pathogenic microorganisms and antimicrobial resistance markers in blood cultures: evaluation and utility of the next-generation FilmArray Blood Culture Identification 2 panel 08 Feb 2022 Early post-discharge mortality in CAP: frequency, risk factors and a prediction tool 08 Feb 2022 Abstract There are few data on mortality after discharge with community-acquired pneumonia (CAP). Therefore, we evaluated risk factors for 30-day post-discharge mortality after CAP. We included all patients of the prospective multi-national CAPNETZ study between 2002 and 2018 with (1) hospitalized CAP, (2) survival until discharge, and (3) complete follow-up data Assessing the diagnostic accuracy of the Xpert MTB/RIF assay in detecting epididymal tuberculosis 07 Feb 2022 Abstract To assess the diagnostic efficacy of Xpert MTB/RIF assay in detecting epididymal tuberculosis. Methods We analyzed 84 samples from patients with suspected epididymal TB or chronic epididymitis who received surgical treatment (epididymal resection or epididymis- testicular resection) at our hospital between July 1, 2016 and July 1, 2020 [back to top] Eurosurveillance latest updates Early chains of transmission of COVID-19 in France, January to March 2020 10 Feb 2022 Introduction SARS-CoV-2, the virus that causes COVID-19, has spread rapidly worldwide. In January 2020, a surveillance system was implemented in France for early detection of cases and their contacts to help limit secondary transmissions. Aim To use contact-tracing data collected during the initial phase of the COVID-19 pandemic to better characterise SARS- CoV-2 transmission Shorter serial intervals in SARS-CoV-2 cases with Omicron BA.1 variant compared with Delta variant, the Netherlands, 13 to 26 December 2021 10 Feb 2022 The SARS-CoV-2 Omicron variant has a growth advantage over the Delta variant because of higher transmissibility, immune evasion or shorter serial interval. Using S gene target failure (SGTF) as indication for Omicron BA.1, we identified 908 SGTF and 1,621 non-SGTF serial intervals in the same period. Within households, the mean serial interval for SGTF cases was 0.2–0 Author's correction for Euro Surveill. 2022;27(3) 10 Feb 2022 Nationwide study on SARS-CoV-2 transmission within households from lockdown to reopening, Denmark, 27 February 2020 to 1 August 2020 10 Feb 2022
Background The COVID-19 pandemic is one of the most serious global public health threats of recent times. Understanding SARS-CoV-2 transmission is key for outbreak response and to take action against the spread of disease. Transmission within the household is a concern, especially because infection control is difficult to apply within this setting Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020 10 Feb 2022 Background The COVID-19 pandemic has led to an unprecedented daily use of RT-PCR tests. These tests are interpreted qualitatively for diagnosis, and the relevance of the test result intensity, i.e. the number of quantification cycles (Cq), is debated because of strong potential biases Investigation of outbreak cases infected with the SARS-CoV-2 B.1.640 variant in a fully vaccinated elderly population, Normandy, France, November to December 2021 10 Feb 2022 Three confirmed infections with the SARS-CoV-2 B.1.640 variant under monitoring were reported in Normandy, north-western France in late November 2021. Investigations led to the identification of two events linked to the same cluster. A total of 75 confirmed and probable B.1.640 cases were reported. All had completed the primary vaccination series. Sixty-two cases were older than 65 years [back to top] Infection Sex differences in COVID-19 mortality in the Netherlands 09 Feb 2022 Abstract Introduction Since the first reports of COVID-19 cases, sex-discrepancies have been reported in COVID-19 mortality. We provide a detailed description of these sex differences in relation to age and comorbidities among notified cases as well as in relation to age and sex-specific mortality in the general Dutch population Creatine kinase-(MB) and hepcidin as candidate biomarkers for early diagnosis of pulmonary tuberculosis: a proof-of-concept study in Lambaréné, Gabon 08 Feb 2022 Abstract Background The present study aimed to evaluate the diagnostic utility of creatine kinase-MB (CK-MB), hepcidin (HEPC), phospholipase A2 group IIA (PLa2G2A), and myosin- binding protein C (MYBPC1) for tuberculosis (TB) The national burden of scabies in Germany: a population-based approach using Internet search engine data 08 Feb 2022 Abstract Purpose Scabies is a World Health Organization-defined neglected tropical disease and a growing public health issue worldwide. It is difficult to obtain reliable data on prevalence due to the lack of standardized tests. The aim of this study was to assess scabies online search behavior in Germany to identify local differences using Google search volume In-utero transmission of SARS CoV-2 infection during delta variant outbreak: first Australian experience 08 Feb 2022 Incidence and severity of COVID-19 infection post-vaccination: a survey among Indian doctors 07 Feb 2022 Abstract Purpose The rollout of COVID-19 vaccines began in India in January 2021, with healthcare professionals being the first to receive vaccination. The purpose of this research was to study the incidence and severity of COVID-19 infections among Indian doctors, following vaccination with ChAdOx1 nCoV-19 or BBV152 [back to top]
Infection Control & Hospital Epidemiology - FirstView Article Applying mucosal barrier injury laboratory-confirmed bloodstream infection criteria in patients with solid tumors and hematologic malignancies: A retrospective cohort study looking for the real source of infection 11 Feb 2022 Published online by Cambridge University Press: Effectiveness of selective digestive decolonization therapy using oral gentamicin for eradication of carbapenem-resistant Enterobacteriaceae carriage 09 Feb 2022 Published online by Cambridge University Press: FebriDx host response point-of-care testing improves patient triage for coronavirus disease 2019 (COVID-19) in the emergency department 31 Jan 2022 Published online by Cambridge University Press: Improving antibiotic use for sinusitis and upper respiratory tract infections: A virtual-visit antibiotic stewardship initiative 31 Jan 2022 Published online by Cambridge University Press: Inactivation of replication-competent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on common surfaces by disinfectants 26 Jan 2022 Published online by Cambridge University Press: [back to top] International Journal of Infectious Diseases A challenging response to a Lassa Fever outbreak in a non-endemic area of Sierra Leone in 2019, with export of cases to the Netherlands 13 Feb 2022 Publication date: Available online 12 February 2022Source: International Journal of Infectious DiseasesAuthor(s): Charles Njuguna, Mohamed Vandi, Evans Liyosi, Jane Githuku, Alie Wurie, Ian Njeru, Philomena Raftery, Claudette Amuzu, Anna Maruta, Robert Musoke, Mukeh Fahnbulleh, Joseph Bunting, Simeon Gbandeh, Ambrose Talisuna, Zabulon Yoti Independent risk factors of COVID-19 pneumonia in vaccinated Mexican adults 13 Feb 2022 Publication date: Available online 12 February 2022Source: International Journal of Infectious DiseasesAuthor(s): Efrén Murillo-Zamora, Ramón Alberto Sánchez-Piña, Xóchitl Trujillo, Miguel Huerta, Mónica Ríos-Silva, Oliver Mendoza-Cano Reduced ADAMTS13 Activity in Correlation with Pathophysiology, Severity, and Outcome of COVID-19; A Retrospective Observational Study 13 Feb 2022 Publication date: Available online 12 February 2022Source: International Journal of Infectious DiseasesAuthor(s): Wael Hafez, Mohamad Azzam Ziade, Arun Arya, Husam Saleh, Sara Ali, Srinivasa Raghu Rao, Osman Fadl Alla, Mohamed Ali, Mouhamad Al Zouhbi, Ahmed Abdelrahman
First outbreak of multi-drug resistant tuberculosis (MDR-TB) in Denmark involving six Danish-born cases 11 Feb 2022 Publication date: Available online 11 February 2022Source: International Journal of Infectious DiseasesAuthor(s): Camilla Hiul Suppli, Anders Norman, Dorte Bek Folkvardsen, Tina Nørregaard Gissel, Ulla Møller Weinreich, Anders Koch, Christian Wejse, Troels Lillebaek Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in Candida spp colonized patients 10 Feb 2022 Publication date: Available online 9 February 2022Source: International Journal of Infectious DiseasesAuthor(s): Elisa Viciani, Paolo Gaibani, Andrea Castagnetti, Andrea Liberatore, Michele Bartoletti, Pierluigi Viale, Tiziana Lazzarotto, Simone Ambretti, Russell Lewis, Monica Cricca Incidence of Severe Acute Respiratory Syndrome Coronavirus-2 infection among previously infected or vaccinated employees 10 Feb 2022 Publication date: Available online 10 February 2022Source: International Journal of Infectious DiseasesAuthor(s): N. Kojima, A. Roshani, M. Brobeck, A. Baca, J.D. Klausner Misdiagnosis of cerebral sparganosis co- existing with HIV/AIDS: a case report 10 Feb 2022 Publication date: Available online 10 February 2022Source: International Journal of Infectious DiseasesAuthor(s): Chun Liu, Zhong Chen, Ummulbanin T. Shaban, Min Wang, Guoqiang Zhou, Ning Wang, Yan Liu Mannose-binding lectin levels and MBL2 gene polymorphisms are associated to dengue infection in Brazilian children at the early ages 10 Feb 2022 Publication date: Available online 9 February 2022Source: International Journal of Infectious DiseasesAuthor(s): Marília A. Sena, Priscila Mayrelle da Silva Castanha, Ana Beatriz Giles Guimarães, Paula Alexandra dos Santos Oliveira, Maria Almerice Lopes da Silva, Marli Tenório Cordeiro, Patricia Moura, Cynthia Braga, Luydson Richardson Silva Vasconcelos Authors’ response to Dr Finsterer's comment “Exclude differentials before diagnosing SARS-CoV-2 associated acute, hemorrhaghic, necrotising encephalitis” 10 Feb 2022 Publication date: Available online 10 February 2022Source: International Journal of Infectious DiseasesAuthor(s): Magdalena Mierzewska-Schmidt, Artur Baranowski, Krystyna Szymanska, Michal Ciaston, Ernest Kuchar, Rafal Ploski, Joanna Kosinska, Izabela Pagowska-Klimek Exclude differentials before diagnosing SARS-CoV-2 assocaited acute, hemorrhaghic, necrotising encephalitis 10 Feb 2022 Publication date: Available online 10 February 2022Source: International Journal of Infectious DiseasesAuthor(s): Josef Finsterer, Daniel Matovu Exploring the Trajectory Recovery Curve of the number of Post-COVID Symptoms: The LONG-COVID-EXP-CM Multicenter Study 09 Feb 2022 Publication date: Available online 9 February 2022Source: International Journal of Infectious DiseasesAuthor(s): César Fernández-de-las-Peñas, José D. Martín-Guerrero, Ignacio Cancela-Cilleruelo, Paloma Moro-López-Menchero, Jorge Rodríguez-Jiménez, Oscar J. Pellicer-Valero Cytomegalovirus Infections in Ugandan Infants: Newborn-Mother Pairs, Neonates with Sepsis, and Infants with Hydrocephalus 09 Feb 2022
Publication date: Available online 9 February 2022Source: International Journal of Infectious DiseasesAuthor(s): Christine Hehnly, Paddy Ssentongo, Lisa M. Bebell, Kathy Burgoine, Joel Bazira, Claudio Fronterre, Elias Kumbakumba, Ronald Mulondo, Edith Mbabazi-Kabachelor, Sarah U. Morton, Joseph Ngonzi, Moses Ochora, Peter Olupot-Olupot, Justin Onen, Drucilla J. Roberts, Kathryn Sheldon, Shamim A Serotype Identification of Human Adenoviruses Associated with Influenza-Like Illnesses in the Philippines from 2006 to 2012 by Microneutralization and Molecular Techniques 09 Feb 2022 Publication date: Available online 9 February 2022Source: International Journal of Infectious DiseasesAuthor(s): Catherine Calzado, Janiza Lianne Foronda, Vina Lea Arguelles, Chona Mae Daga, Marie Therese Quimpo, Socorro Lupisan, Clyde Dapat, Mariko Saito, Michiko Okamoto, Pia Marie Albano, Hitoshi Oshitani Interventional research to tackle antimicrobial resistance in Low Middle Income Countries in the era of the COVID-19 pandemic: lessons in resilience from an international consortium 09 Feb 2022 Publication date: Available online 9 February 2022Source: International Journal of Infectious DiseasesAuthor(s): Gabriel BIRGAND, Esmita CHARANI, Raheelah AHMAD, Candice BONACONSA, Oluchi MBAMALU, Vrinda NAMPOOTHIRI, Surya SURENDRAN, Tom. G. WEISER, Alison HOLMES, Marc MENDELSON, Sanjeev SINGH, ASPIRES study researchers Potential use of antibodies to provide an earlier indication of lymphatic filariasis resurgence in post-mass drug administration surveillance, American Samoa 09 Feb 2022 Publication date: Available online 9 February 2022Source: International Journal of Infectious DiseasesAuthor(s): Angela M. Cadavid Restrepo, Katherine Gass, Kimberly Y. Won, Meru Sheel, Keri Robinson, Patricia M. Graves, Saipale Fuimaono, Colleen L. Lau Performance of anterior nares and tongue swabs for nucleic acid, Nucleocapsid and Spike antigen testing for detecting SARS-CoV-2 against nasopharyngeal PCR and viral culture 09 Feb 2022 Publication date: Available online 9 February 2022Source: International Journal of Infectious DiseasesAuthor(s): Michalina A Montaño, Meagan J. Bemer, Kate B Heller, Allison Meisner, Zarna Marfatia, Elena A. Rechkina, Leah R. Padgett, Charlotte L. Ahls, Douglas Rains, Linhui Hao, Tien-Ying Hsiang, Gerard A. Cangelosi, Alexander L. Greninger, Jason L. Cantera, Allison Golden, Roger B Severity of the clinical presentation of hepatitis A in five European countries from 1995 to 2014 07 Feb 2022 Publication date: Available online 5 February 2022Source: International Journal of Infectious DiseasesAuthor(s): Ettore Severi, Leonidas Georgalis, Roan Pijnacker, Lamprini Veneti, Iulia Adelina Turiac, Flaminia Chiesa, Caterina Rizzo, Domenico Martinelli, Line Vold, Bernardo Guzman Herrador, Carmen Varela Martinez, Elena Vanessa Martinez Sanchez, Jan C Molecular Epidemiology and Genetic Diversity of Mycobacterium tuberculosis Complex in Referral Health Centres of Bamako, Mali: What is New? 07 Feb 2022 Publication date: Available online 5 February 2022Source: International Journal of Infectious DiseasesAuthor(s): Bourahima Kone, Anou M. Somboro, Mahamadou Kone, Jane L. Holl, Bocar Baya, Djeneba Dabitao, Dramane Diallo, Bassirou Diarra, Amadou Kone, Yeya Dit Sadio Sarro, Moumine Sanogo, Antieme CG Togo, Robert L
You can also read